tiprankstipranks
Trending News
More News >
Oxford Biomedica (otc) (DE:OXOA)
:OXOA
Germany Market

Oxford BioMedica (OXOA) Financial Statements

Compare
0 Followers

Oxford BioMedica Financial Overview

Oxford BioMedica's market cap is currently €385.98M. The company's EPS TTM is €-0.481; its P/E ratio is ―; Oxford BioMedica is scheduled to report earnings on ―, and the estimated EPS forecast is €-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue£ 128.80M£ 89.54M£ 139.99M£ 142.80M£ 87.73M
Gross Profit£ 53.02M£ 39.73M£ 69.18M£ 82.64M£ 46.07M
Operating Income£ -39.38M£ -184.17M£ -51.56M£ 20.77M£ -4.83M
EBITDA£ -14.33M£ -148.62M£ -10.86M£ 33.22M£ 3.92M
Net Income£ -43.19M£ -157.49M£ -45.16M£ 19.01M£ -6.25M
Balance Sheet
Cash & Short-Term Investments£ 60.65M£ 103.72M£ 141.31M£ 109.02M£ 46.98M
Total Assets£ 231.64M£ 252.34M£ 460.18M£ 237.23M£ 183.93M
Total Debt£ 108.76M£ 111.46M£ 114.28M£ 9.34M£ 13.85M
Net Debt£ 48.11M£ 7.74M£ -27.00M£ -99.60M£ -32.90M
Total Liabilities£ 171.16M£ 174.51M£ 223.99M£ 49.89M£ 71.18M
Stockholders' Equity£ 57.05M£ 74.01M£ 204.65M£ 187.34M£ 112.75M
Cash Flow
Free Cash Flow£ -58.12M£ -38.35M£ -28.91M£ 15.99M£ -10.24M
Operating Cash Flow£ -50.63M£ -28.52M£ -12.62M£ 25.45M£ 3.12M
Investing Cash Flow£ 5.63M£ 2.81M£ -56.46M£ -9.46M£ -10.80M
Financing Cash Flow£ 2.91M£ -12.70M£ 98.62M£ 46.21M£ 38.19M
Currency in GBP

Oxford BioMedica Earnings and Revenue History

Oxford BioMedica Debt to Assets

Oxford BioMedica Cash Flow

Oxford BioMedica Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis